+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line



Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line



Proceedings of the National Academy of Sciences of the United States of America 75(3): 1519-1523



We reported previously that, by mutagenesis of a malignant teratocarcinoma cell line, it is possible to obtain a number of variant clones that are incapable of forming progressive tumors. Each of these "tum-" variants is rejected in syngeneic mice and stimulates the production of immune memory cells (self-protection). We show here that four different tum- clones confer an immune protection against each other although this cross-protection is invariably weaker than the self-protection. Moreover, mice immunized with living tum- cells are partially protected against the original malignant teratocarcinoma cells, even though the latter cells are incapable of conferring any immune protection when injected after being killed by irradiation. These results indicate that each tum- variant carries at least one specific transplantation antigen that is absent from the original tumor cell line and from most other tum- variants. Other tumor-specific transplantation antigens are probably present on all the tum- variants and also on the malignant teratocarcinoma cell line.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041544730

Download citation: RISBibTeXText

PMID: 274738

DOI: 10.2307/68033


Related references

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proceedings of the National Academy of Sciences of the United States of America 74(1): 272-275, 1977

Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice. Proceedings of the National Academy of Sciences of the United States of America 76(10): 5282-5285, 1979

Isolation in newborn mice of tumour cell variants from a polyoma-transformed non-malignant cell line. European Journal of Cancer 8(1): 107-109, 1972

H-2 antigen variants in a cultured heterozygous mouse leukemia cell line. VI. Rate of emergence of the hemizygous variants and evidence that the variants preexist the selection. Immunogenetics 10(5): 411-422, 1980

Antigenic variants of influenza A virus IV Serological characteristics of a second line of variants developed in mice given polyvalent vaccine. Jour Exptl Med: 845-855, 1958

Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine. Journal of Experimental Medicine 107(6): 845-855, 1958

Antigenic variants of influenza A virus ID Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. Jour Exptl Med: 829-844, 1958

Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. Journal of Experimental Medicine 107(6): 829-844, 1958

Aggregation-deficient variants of the H6 teratocarcinoma cell line. Progress in Clinical and Biological Research 97: 173-192, 1982

Differential expression of cell membrane antigens and tumorigenicity in nude mice of human urothelial cell line hcv 29 and its v raf transfected variants. Anticancer Research 10(5 Part B): 1396, 1990

Colon-cancer cell variants producing regressive tumors in syngeneic rats, unlike variants yielding progressive tumors, attach to interstitial collagens through integrin alpha2beta1. International Journal of Cancer 65(6): 796-804, 1996

Differential expression of cell membrane antigens, cytotoxic sensitivity, and tumorigenicity in athymic nude mice of a human urothelial cell line and its v-raf-transfected variants. Fiebig, H H, Berger, D P Contributions to Oncology; Immunodeficient mice in oncology: 231-245, 1992

Metastatic variants of a human lung carcinoma cell line isolated using athymic mice. Journal of Cellular Biochemistry Suppl. (11 Part D): 103, 1987

Characterization of variants of a human breast-cancer cell-line isolated from metastases in different organs of nude-mice. International Journal of Oncology 5(3): 459-467, 1994

Immunogenic cell variants of a mouse terato carcinoma confer protection against the original nonimmunogenic transplantable tumor. European Journal of Cancer & Clinical Oncology 17(10): 1083-1088, 1981